Content area


Muligt klinisk potentiale ved revertering af neuromuskulær blokade med sugammadex ved anæstesi og kirurgi

Emilie Øberg1 & Casper Claudius2 1) Anæstesiologisk Afdeling, Herlev Hospital2) Anæstesiologisk Afdeling, Bispebjerg Hospital
Ugeskr Læger 2013;175(7):428-432
Blad nummer: 
Summary Possible clinical potential in reverting muscular block with sugammadex in anaesthesia and surgery Ugeskr Læger 2013;175(7):428-432 Neuromuscular blockers (NMBs) provide good conditions for endotracheal intubation and surgery. NMBs have been associated with higher morbidity and mortality, mainly due to postoperative residual neuromuscular block. This may become history with the advent of sugammadex - an antidote to the NMB rocuronium - which within 1-3 minutes neutralizes the effects of rocuronium. High-dose rocuronium is now an alternative to suxamethonium in acute or short procedures and in a situation, where ventilation/intubating cannot be performed, sugammadex can reverse the rocuronium blockade within minutes.
Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Bo Hasseriis Hansen | 19/01
2 kommentarer
af Johan Ludvig Reventlow | 18/01
1 Kommentar
af Claus Manniche | 18/01
1 Kommentar
af Bjarne Skjødt Hjaltalin | 18/01
1 Kommentar
af Yngve Lund | 17/01
13 kommentarer
af Jens Meyer Svendsen | 16/01
1 Kommentar
af Claus Rasmussen | 16/01
3 kommentarer
af Thomas Eric Olesen | 15/01
2 kommentarer